The past week was filled with news about the new coronavirus and the COVID-19 disease that it causes. This story continues to evolve, so it makes no sense to refer you to one of last week’s stories on the subject. Instead, check out the Coronavirus/COVID-19 Information topic on our Multiple Sclerosis News Today Forums. Co-moderator John Connor and I are posting the freshest information there.
Meanwhile, in other news …
This is disappointing news about what scientists had hoped would be another oral disease-modifying therapy for multiple sclerosis. It’s doubly disappointing because MD1003 is aimed at progressive forms of MS and demyelination, and we need more of those treatments in the MS toolkit.
Click here to read the full story.
I like the idea of a combined THC/CBD spray that provides relief for pain and spasticity. I could use some relief from my spasticity, but mine isn’t severe enough to warrant this treatment. Additionally, another medication needs to be used in combination with Sativex (nabiximols) to achieve improvement, so it seems far from an ideal solution. Sativex is approved for use in some European countries, but it’s still undergoing clinical trials in the U.S.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?